Additionally, partial biological validation was performed, with Western blotting analysis indicating higher expression of TRGV9 in a normal cell line compared to three other lung adenocarcinoma cell lines (Fig. 10m), corroborating the results from our dataset analysis. The gene discussed is TRGV9; the disease is lung adenocarcinoma.